Journal
FEBS LETTERS
Volume 593, Issue 24, Pages 3449-3460Publisher
WILEY
DOI: 10.1002/1873-3468.13649
Keywords
adenovirus; complement; natural antibody; gene therapy; immunoglobulin G; immunoglobulin M; tripartite motif-containing protein 21; vitamin K-dependent coagulation factors
Ask authors/readers for more resources
Adenovirus (AdV) is one of the most widely used vectors for gene therapy and vaccine studies due to its excellent transduction efficiency, capacity for large transgenes, and high levels of gene expression. When administered intravascularly, the fate of AdV vectors is heavily influenced by interactions with host plasma proteins. Some plasma proteins can neutralize AdV, but AdV can also specifically bind plasma proteins that protect against neutralization and preserve activity. This review summarizes the plasma proteins that interact with AdV, including antibodies, complement, and vitamin K-dependent coagulation factors. We will also review the complex interactions of these plasma proteins with each other and with cellular proteins, as well as strategies for developing better AdV vectors that evade or manipulate plasma proteins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available